VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Presents Non-Human Primate Study Data at AIDS Vaccine 2008 Conference

BLUE BELL, Pa.--(BUSINESS WIRE)--VGX Pharmaceuticals (VGXP), a developer of DNA vaccines against cancer and infectious diseases, presented today non-human primate study data from both its PENNVAX™ HIV Vaccine Program and its patented CELLECTRA® DNA Delivery technology in two presentations at the AIDS Vaccine 2008 Conference currently taking place in Cape Town, South Africa.
MORE ON THIS TOPIC